Nachrichten zur Abbvie Inc. Aktie

AbbVie Is Raising Several Green Flags

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AbbVie (ABBV) Gains But Lags Market: What You Should Know

In the latest trading session, AbbVie (ABBV) closed at $112.62, marking a +0.39% move from the previous day....…

AbbVie: Undervalued Dividend Aristocrat Offering A 4.77% Yield

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference

NORTH CHICAGO, Ill. , Jan. 15, 2021 /PRNewswire/ -- Allergan Aesthetics and Allergan, an AbbVie company (NYSE: ABBV), announced today…

AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know

AbbVie (ABBV) closed at $111.63 in the latest trading session, marking a -0.73% move from the prior day....…

AbbVie (ABBV) Inks Deal to Acquire Medical Device Company

AbbVie (ABBV) signs an agreement to acquire privately held Cypris Medical, including the latters Xact device which is used for…

Evolus is up 6% after AbbVie-Cypris Medical deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Genmab receives $40M milestone payment in AbbVie collaboration

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Genmab Achieves USD 40 Million Milestone in Collaboration with AbbVie

Company Announcement...…

AbbVie Inc. (ABBV) CEO Rick Gonzalez Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know

AbbVie (ABBV) closed at $109.78 in the latest trading session, marking a +0.7% move from the prior day....…

AbbVie Inc.: 8-K Report

FORM 8-K...…

Allergan Aesthetics Enters Into Option to Acquire Cypris Medical

IRVINE, Calif. , Jan. 12, 2021 /PRNewswire/ -- Today Allergan Aesthetics, an AbbVie company…

Dragonfly Therapeutics Announces AbbVie Opt-In of TriNKET™ Immunotherapy Drug Candidate

Dragonfly to receive payment for the first Opt-In from AbbVie as part of a multi-target collaboration launched…

AbbVie (ABBV) Gains As Market Dips: What You Should Know

AbbVie (ABBV) closed at $109.02 in the latest trading session, marking a +1.63% move from the prior day....…

AbbVie rated buy at Mizuho despite patent cliff for Humira

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Dividend Diligence On AbbVie With Seeking Alpha

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AbbVie Looks Attractive Despite Headwinds

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

How Patience Paid Off for Jim Cramer With AbbVie

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Case for AbbVie as a Top Biopharma Stock in 2021

Mizuho analyst Vamil Divan said he is bullish about the sector, citing continued innovation, a favorable environment in Washington, and…

AbbVie Inc.: 8-K Report

FORM 8-K...…

Why AbbVie (ABBV) Could Beat Earnings Estimates Again

AbbVie (ABBV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

AbbVie to Present at the 39th Annual J.P. Morgan Healthcare Conference

NORTH CHICAGO, Ill. , Jan. 6, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate…

AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know

AbbVie (ABBV) closed at $106.50 in the latest trading session, marking a +1.03% move from the prior day....…

Abbvie returns global rights to muscarinic agonist programs to Sosei

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Drugmakers kick off 2021 with 500 U.S. price hikes

Drugmakers including Abbvie Inc and Bristol Myers Squibb raised U.S. list prices on more than 500 drugs to kick off…

The Zacks Analyst Blog Highlights: Johnson & Johnson, NVIDIA, Cisco, AbbVie and Sony

The Zacks Analyst Blog Highlights: Johnson & Johnson, NVIDIA, Cisco, AbbVie and Sony...…

AbbVie (ABBV) Gains As Market Dips: What You Should Know

AbbVie (ABBV) closed at $104.70 in the latest trading session, marking a +1.21% move from the prior day....…

Biotech-Deals Schlag auf Schlag: Myovant macht die +100% voll

Die Oktober-Empfehlung der Experten aus dem NBC-Gremium, Myovant Sciences (WKN: A2DFYA), lässt heute die AbbVie-Zentrale erzittern. Die Kursgewinne schnellen in…

Construction Partners, Surgery Partners, Qualcomm, AbbVie and Garmin as Zacks Bull and Bear of the Day

Construction Partners, Surgery Partners, Qualcomm, AbbVie and Garmin as Zacks Bull and Bear of the Day...…

AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know

AbbVie (ABBV) closed at $102.80 in the latest trading session, marking a -0.88% move from the prior day....…

AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, AbbVie (ABBV) closed at $104.64, marking a +1.77% move from the previous day....…

AbbVie Wins Bid to Block U.S. Imports of a Botox Rival

AbbVie Wins Bid to Block U.S. Imports of a Botox Rival...…

AbbVie (ABBV) Presents Immunology Strategy Update and Long Term Outlook - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Final Trades: AMD, AbbVie, Wingstop & more

The "Halftime Report" traders give their top picks to watch for the second half....…

Big Pharma Passes Its Annual Checkup

Upbeat outlooks from AbbVie and Lilly dont depend on coronavirus drugs, which should have investors encouraged....…

Pharmabranche - Roche und Partner AbbVie erhalten kanadische Zulassung für Krebstherapie

Roche und der Forschungspartner AbbVie dürfen in Zukunft ihre Krebstherapie Venclexta (venetoclax) auch in Kanada vermarkten....…

Roche und Partner AbbVie erhalten kanadische Zulassung für Venclexta

BASEL (dpa-AFX) - Roche und der Forschungspartner AbbVie dürfen in Zukunft ihre Krebstherapie Venclexta (venetoclax) auch in Kanada vermarkten. Wie…

Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials

Um den gesamten Artikel unter barchart.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nike, FedEx, Lennar, Eli Lilly, and Other Stocks to Watch This Week

Earnings reports and investor days from FedEx, Nike, General Mills, AbbVie, Eli Lilly, and more. Plus, a Federal Reserve decision,…

AbbVie: No Sense Of (Post) Humira Failure - My Price Target Is $120 - $150

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AbbVie says Rinvoq achieved superiority versus Dupixent in atopic dermatitis study

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

RINVOQ™ (upadacitinib) Achieved Superiority Versus DUPIXENT® (dupilumab) For Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis

NORTH CHICAGO, Ill. , Dec. 10, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced…

AbbVie announces positive late-stage data for upadacitinib in Ulcerative Colitis

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Upadacitinib (RINVOQ™) Meets Primary and All Ranked Secondary Endpoints in First Phase 3 Induction Study in Ulcerative Colitis

NORTH CHICAGO, Ill. , Dec. 9, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive…